Search for: "BRISTOL MYERS SQUIBB" Results 201 - 220 of 867
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2016, 8:01 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
12 Apr 2016, 10:57 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
12 Aug 2011, 12:20 pm
Li works as a chemist for Bristol Myers Squibb. [read post]
19 Aug 2011, 6:30 am
Stanford University researchers recently reported a new drug interaction between paroxetine (Paxil, GlaxoSmithKline) and pravastatin (Pravachol, Bristol-Myers Squibb), which may lead to diabetes in prone individuals, or worsen present diabetes cases. [read post]
10 Dec 2018, 5:01 am by Kit Case
ZymoGenetics, after being purchased by Bristol-Myers Squibb, has been winding down their Seattle presence, first noted when they chose to not renew their lease of the historic Lake Union Steam Plant building in 2016. [read post]
21 Nov 2010, 9:02 pm by Patent Docs
Bristol-Myers Squibb Co. 2:10-cv-00497; filed November 18, 2010 in the Eastern District of Texas False marking based on BMS' marking of its Cefzil products, its Buspar products, and its Pravachol products U.S. [read post]
3 Feb 2010, 2:39 am by Mark Zamora
Didanosine, marketed by Bristol-Myers Squibb under the brand names Videx and Videx EC (an extended release version), was approved by the FDA in 1991, joining AZT as the only drugs then approved to treat HIV. [read post]
12 Feb 2018, 12:05 pm by Tom Lamb
Continuing, this Kombiglyze / Onglyza MDL Transfer Order sets forth the JPML's take on that contention by AstraZeneca, Bristol-Myers Squibb, and McKesson: Defendants concede that most cases involve allegations of heart failure, which is squarely in line with the results of the SAVOR study and the subsequent label change for Onglyza and Kombiglyze XR in April 2016. [read post]
18 Sep 2021, 8:45 pm by Patent Docs
.; Henry Hadad of Bristol-Myers Squibb; Joshua Rosenkranz of Orrick, Herrington & Sutcliffe LLP; and John Whealan of The George Washington... [read post]
27 Jun 2017, 8:00 am by The Editors
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
25 Jun 2021, 4:15 am by Logan Murr
., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
28 Apr 2020, 6:31 am by Howard Wasserman
MDT, noon PDT), Tuesday, May 5; Alexi Lahav (UConn) will discuss Bristol-Myers Squibb: Going Forward. [read post]
15 Jan 2022, 8:42 pm by Patent Docs
Elsby of Akin Gump will moderate a panel consisting of Paul Golian of Bristol Myers Squibb and Paula Fritsch of Amgen. [read post]